![]() |
Name |
Asperterpenoid A
|
Molecular Formula | C25H38O3 | |
IUPAC Name* |
(1S,2R,4R,5S,11S,14S,17R,18S)-11-(hydroxymethyl)-4,14-dimethyl-17-propan-2-ylpentacyclo[9.7.0.02,4.05,9.014,18]octadec-8-ene-8-carboxylic acid
|
|
SMILES |
CC(C)[C@H]1CC[C@@]2([C@@H]1[C@@H]3[C@H]4C[C@]4([C@@H]5CCC(=C5C[C@]3(CC2)CO)C(=O)O)C)C
|
|
InChI |
InChI=1S/C25H38O3/c1-14(2)15-7-8-23(3)9-10-25(13-26)11-17-16(22(27)28)5-6-18(17)24(4)12-19(24)21(25)20(15)23/h14-15,18-21,26H,5-13H2,1-4H3,(H,27,28)/t15-,18-,19-,20+,21+,23+,24+,25-/m1/s1
|
|
InChIKey |
IVOQOKYIPJPDKP-LQAIXYHKSA-N
|
|
Synonyms |
Asperterpenoid A; CHEMBL4583298; BDBM50523085; hydroxymethyl-isopropyl-dimethyl-[?]carboxylic acid
|
|
CAS | NA | |
PubChem CID | 71578630 | |
ChEMBL ID | CHEMBL4583298 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 386.6 | ALogp: | 5.5 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.5 | Aromatic Rings: | 5 |
Heavy Atoms: | 28 | QED Weighted: | 0.669 |
Caco-2 Permeability: | -5.204 | MDCK Permeability: | 0.00001380 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.029 |
Blood-Brain-Barrier Penetration (BBB): | 0.919 | Plasma Protein Binding (PPB): | 97.74% |
Volume Distribution (VD): | 0.786 | Fu: | 2.81% |
CYP1A2-inhibitor: | 0.04 | CYP1A2-substrate: | 0.291 |
CYP2C19-inhibitor: | 0.017 | CYP2C19-substrate: | 0.837 |
CYP2C9-inhibitor: | 0.157 | CYP2C9-substrate: | 0.101 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.101 |
CYP3A4-inhibitor: | 0.51 | CYP3A4-substrate: | 0.307 |
Clearance (CL): | 1.766 | Half-life (T1/2): | 0.341 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.265 |
Drug-inuced Liver Injury (DILI): | 0.065 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.184 | Maximum Recommended Daily Dose: | 0.038 |
Skin Sensitization: | 0.054 | Carcinogencity: | 0.271 |
Eye Corrosion: | 0.01 | Eye Irritation: | 0.057 |
Respiratory Toxicity: | 0.96 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003725 | ![]() |
0.411 | D0KR5B | ![]() |
0.310 | ||
ENC003939 | ![]() |
0.360 | D04SFH | ![]() |
0.295 | ||
ENC003938 | ![]() |
0.336 | D0I2SD | ![]() |
0.295 | ||
ENC002278 | ![]() |
0.333 | D03ZTE | ![]() |
0.294 | ||
ENC005894 | ![]() |
0.326 | D0G3SH | ![]() |
0.294 | ||
ENC004664 | ![]() |
0.319 | D0Q6NZ | ![]() |
0.288 | ||
ENC003050 | ![]() |
0.312 | D0IX6I | ![]() |
0.287 | ||
ENC003804 | ![]() |
0.311 | D0M4WA | ![]() |
0.282 | ||
ENC005747 | ![]() |
0.308 | D0R7JT | ![]() |
0.282 | ||
ENC002305 | ![]() |
0.306 | D07BSQ | ![]() |
0.282 |